Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:AGTC
Delisted

Applied Genetic Technologies Corporation Stock Price (Quote)

$0.397
+0 (+0%)
At Close: Feb 28, 2023

Range Low Price High Price Comment
30 days $0.397 $0.397 Tuesday, 28th Feb 2023 AGTC stock ended at $0.397. During the day the stock fluctuated 0% from a day low at $0.397 to a day high of $0.397.
90 days $0.370 $0.400
52 weeks $0.230 $2.03

Historical Applied Genetic Technologies Corporation prices

Date Open High Low Close Volume
Nov 23, 2016 $9.50 $10.00 $9.35 $9.85 83 693
Nov 22, 2016 $10.05 $10.10 $9.50 $9.70 88 322
Nov 21, 2016 $10.15 $10.20 $9.68 $9.95 122 875
Nov 18, 2016 $9.85 $10.40 $9.75 $10.05 147 319
Nov 17, 2016 $9.45 $10.05 $9.33 $9.60 133 450
Nov 16, 2016 $10.15 $10.25 $9.25 $9.35 189 905
Nov 15, 2016 $10.60 $10.85 $10.05 $10.10 235 460
Nov 14, 2016 $10.00 $10.65 $9.70 $10.55 308 263
Nov 11, 2016 $9.35 $10.00 $9.25 $9.85 245 142
Nov 10, 2016 $9.30 $9.95 $9.20 $9.40 331 220
Nov 09, 2016 $8.00 $9.30 $7.70 $9.15 522 427
Nov 08, 2016 $7.05 $7.05 $7.05 $7.05 122 245
Nov 07, 2016 $7.20 $7.20 $7.20 $7.20 132 100
Nov 04, 2016 $6.60 $6.60 $6.60 $6.60 108 200
Nov 03, 2016 $6.35 $6.35 $6.35 $6.35 137 000
Nov 02, 2016 $6.55 $6.55 $6.55 $6.55 83 500
Nov 01, 2016 $6.85 $6.85 $6.85 $6.85 140 100
Oct 31, 2016 $7.15 $7.15 $7.15 $7.15 80 300
Oct 28, 2016 $7.40 $7.40 $7.40 $7.40 111 000
Oct 27, 2016 $7.50 $7.50 $7.50 $7.50 144 400
Oct 26, 2016 $7.95 $7.95 $7.95 $7.95 243 400
Oct 25, 2016 $8.10 $8.10 $8.10 $8.10 100 900
Oct 24, 2016 $8.20 $8.20 $8.20 $8.20 134 600
Oct 21, 2016 $8.25 $8.25 $8.25 $8.25 134 000
Oct 20, 2016 $9.00 $9.00 $9.00 $9.00 272 200
Click to get the best stock tips daily for free!

About Applied Genetic Technologies Corporation

Applied Genetic Technologies Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing... AGTC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT